{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Level+3&page=12", "query": { "intervention": "Level 3", "page": 12 }, "page_size": 10 }, "pagination": { "page": 12, "page_size": 10, "total_count": 5901, "total_pages": 591, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Level+3&page=13&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Level+3&page=11&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T20:15:20.147Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06177171", "title": "Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "BRCA1 Mutation", "BRCA2 Mutation", "BRCA Mutation", "PALB2 Gene Mutation", "Checkpoint Kinase 2 Gene Mutation", "ATM Gene Mutation" ], "interventions": [ { "name": "Olaparib", "type": "DRUG" }, { "name": "ASTX727", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Varun Monga, MBBS", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 13, "start_date": "2024-02-07", "completion_date": "2028-01-31", "has_results": false, "last_update_posted_date": "2026-10-20", "last_synced_at": "2026-10-22T20:15:20.147Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06177171" }, { "nct_id": "NCT04246671", "title": "TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Chordoma", "HER2-positive Breast Cancer" ], "interventions": [ { "name": "TAEK-VAC-HerBy", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Bavarian Nordic", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 37, "start_date": "2020-08-10", "completion_date": "2024-12-11", "has_results": false, "last_update_posted_date": "2025-03-03", "last_synced_at": "2026-10-22T20:15:20.147Z", "location_count": 9, "location_summary": "Scottsdale, Arizona • Santa Monica, California • Jacksonville, Florida + 6 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Santa Monica", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04246671" }, { "nct_id": "NCT05294471", "title": "Fully Automated High-Throughput Quantitative MRI of the Liver", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Healthy", "Iron Overload", "Liver Fat" ], "interventions": [ { "name": "Non-contrast MRI with novel MRI software", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "7 Years", "maximum_age": null, "sex": "ALL", "summary": "7 Years and older" }, "enrollment_count": 204, "start_date": "2023-10-16", "completion_date": "2026-10", "has_results": false, "last_update_posted_date": "2026-09-16", "last_synced_at": "2026-10-22T20:15:20.147Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT05294471" }, { "nct_id": "NCT06251544", "title": "TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Breast Cancer", "Tumor, Breast", "Breast Tumor", "Malignant Neoplasm of Breast", "Mammary Cancer", "Mammary Neoplasm", "Mammary Neoplasms, Human", "Neoplasm, Breast" ], "interventions": [ { "name": "HTR2 T Cells", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 27, "start_date": "2026-08-03", "completion_date": "2044-01", "has_results": false, "last_update_posted_date": "2026-09-24", "last_synced_at": "2026-10-22T20:15:20.147Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06251544" }, { "nct_id": "NCT05159700", "title": "A Phase I Study, Evaluating the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Solid Tumor", "Advanced Solid Malignancies" ], "interventions": [ { "name": "PRJ1-3024", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zhuhai Yufan Biotechnologies Co., Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 39, "start_date": "2022-03-31", "completion_date": "2026-06-29", "has_results": false, "last_update_posted_date": "2025-12-15", "last_synced_at": "2026-10-22T20:15:20.147Z", "location_count": 6, "location_summary": "Denver, Colorado • Orlando, Florida • Cincinnati, Ohio + 3 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Orlando", "state": "Florida" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Austin", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05159700" }, { "nct_id": "NCT02101034", "title": "PD 0332991 and Cetuximab in Patients With Incurable SCCHN", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Carcinoma, Squamous Cell of Head and Neck" ], "interventions": [ { "name": "Cetuximab", "type": "BIOLOGICAL" }, { "name": "PD 0332991", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 96, "start_date": "2014-06-17", "completion_date": "2023-11-10", "has_results": true, "last_update_posted_date": "2023-12-21", "last_synced_at": "2026-10-22T20:15:20.147Z", "location_count": 5, "location_summary": "Atlanta, Georgia • Westwood, Kansas • Ann Arbor, Michigan + 2 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Westwood", "state": "Kansas" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02101034" }, { "nct_id": "NCT00489281", "title": "Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood Disorders", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sickle Cell Disease" ], "interventions": [ { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Mycophenolate mofetil", "type": "DRUG" }, { "name": "Sirolimus", "type": "DRUG" }, { "name": "Allogeneic bone marrow transplant", "type": "PROCEDURE" }, { "name": "Total body irradiation - 200", "type": "RADIATION" }, { "name": "Levetiracetam", "type": "DRUG" }, { "name": "Anti-thymocyte globulin", "type": "BIOLOGICAL" }, { "name": "Total body irradiation - 400", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "PROCEDURE", "RADIATION", "BIOLOGICAL" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "2 Years to 70 Years" }, "enrollment_count": 43, "start_date": "2008-06-23", "completion_date": "2018-12-29", "has_results": true, "last_update_posted_date": "2019-04-17", "last_synced_at": "2026-10-22T20:15:20.147Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00489281" }, { "nct_id": "NCT02829528", "title": "Little Flower Yoga for Kids: Evaluation of a Yoga and Mindfulness Program for Children With Increased Levels of Emotion Dysregulation and Inattention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "ADHD" ], "interventions": [ { "name": "Little Flower Yoga For Kids", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "New York University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "7 Years", "sex": "FEMALE", "summary": "5 Years to 7 Years · Female only" }, "enrollment_count": 15, "start_date": "2016-09", "completion_date": "2017-06", "has_results": false, "last_update_posted_date": "2022-11-04", "last_synced_at": "2026-10-22T20:15:20.147Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02829528" }, { "nct_id": "NCT07227792", "title": "Tongue-out Radiation Therapy (TORT) for the Mitigation of Radiotherapy-related Toxicities in Patients With Head and Neck Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Head and Neck Carcinoma" ], "interventions": [ { "name": "Tongue-out radiation therapy (TORT)", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "Yvonne Mowery", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2025-11-23", "completion_date": "2029-01-31", "has_results": false, "last_update_posted_date": "2025-12-17", "last_synced_at": "2026-10-22T20:15:20.147Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT07227792" }, { "nct_id": "NCT02279095", "title": "An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fibrodysplasia Ossificans Progressiva" ], "interventions": [ { "name": "Palovarotene dose level 1", "type": "DRUG" }, { "name": "Palovarotene dose level 2", "type": "DRUG" }, { "name": "Palovarotene dose level 3", "type": "DRUG" }, { "name": "Palovarotene dose level 4", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Clementia Pharmaceuticals Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "6 Years to 65 Years" }, "enrollment_count": 58, "start_date": "2014-10-09", "completion_date": "2022-09-20", "has_results": true, "last_update_posted_date": "2025-02-19", "last_synced_at": "2026-10-22T20:15:20.147Z", "location_count": 3, "location_summary": "San Francisco, California • Rochester, Minnesota • Philadelphia, Pennsylvania", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02279095" } ] }